AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
Migrate infobox: document_type -> document_category; add specific form as document_type |
||
| (7 intermediate revisions by the same user not shown) | |||
Line 4:
| period = FY
| period_label = FY25
|
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
* ''
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
*
* ''
*
*
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
=== Table of contents ===
*
*
*
== FY25 Highlights ==
* Section divider slide for ''
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
|
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
|
|-
| style="text-align:left" | Return on equity
|
|-
| style="text-align:left" | Solvency II ratio
|
|-
| style="text-align:left" |
|
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" |
|
|}
</div>
* Dividend
* Share buyback approved by
=== Executing the plan on growth, margin and efficiency ===
Line 74 ⟶ 76:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
Line 88 ⟶ 90:
|}
</div>
*
* Record profitability:
* Scaling the business:
*
=== Diversified franchise, well positioned in an attractive industry ===
Line 97 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 108 ⟶ 110:
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
*
* ''Our right to win'' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
** Technical expertise to price & underwrite risks
** Scale offering cost advantage
=== Laying the foundation for the next plan ===
*
** ''Clear tech'' and AI roadmap <sup>p. 8</sup>
** ''Driving efficiency'' across operations <sup>p. 8</sup>
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup>
** ''Building resilience'' across the business <sup>p. 8</sup>
*
=== FY25 business performance ===
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
<div style="overflow-x:auto">
{| class="wikitable
|+ Gross written premiums and underlying earnings by region FY25 <sup>p. 10</sup>
!
! class="col-
! class="col-
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|}
</div>
Line 185 ⟶ 175:
=== P&C | Strong margins, confidence in sustaining growth ===
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>.
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* ''AXA XL (Large & Specialty)'' strategic outlook:
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* ''Earnings drivers'' supporting performance:
** Continued progress on efficiency <sup>p. 11</sup>.
** Higher investment income <sup>p. 11</sup>.
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
== Financial Performance ==
=== FY25
* ''Section
=== P&C | Continued disciplined growth ===
Line 256 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP &
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 293 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 302 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio bridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total combined ratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Prior year reserve development shows lower reliance
* Reserve prudence enhanced by taking advantage of a good year
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 372 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m.
*
*
*
*
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 385 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 411 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +
|-
| style="text-align:left" | Individual
Line 441 ⟶ 389:
| style="text-align:right" | +4%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
Line 450 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Unit-
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Capital light
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
Line 485 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 496 ⟶ 449:
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-
| style="text-align:right" | —
| style="text-align:right" | 8.5
Line 510 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
Line 520 ⟶ 468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
Line 530 ⟶ 478:
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
Line 548 ⟶ 486:
</div>
*
*
*
*
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 557 ⟶ 495:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" |
| style="text-align:right" | +2.2
|-
| style="text-align:left" |
| style="text-align:right" | +1.3
|-
Line 573 ⟶ 511:
| style="text-align:right" | -3.0
|-
| style="text-align:left" |
| style="text-align:right" | +0.6
|-
| style="text-align:left" |
| style="text-align:right" | -0.3
|-
| style="text-align:left" |
| style="text-align:right" | -1.4
|-
Line 587 ⟶ 525:
</div>
*
*
*
*
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 603 ⟶ 539:
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
| style="text-align:left" |
| style="text-align:right" | +60
|-
| style="text-align:left" |
| style="text-align:right" | +156
|-
| style="text-align:left" |
| style="text-align:right" | -11
|-
| style="text-align:left" |
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* ''
*
* ''
* ''
*
*
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 635 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Property & Casualty
Line 659 ⟶ 597:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
Line 670 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 3.59
|-
| style="text-align:left" |
| style="text-align:right" | +6%
|-
| style="text-align:left" |
| style="text-align:right" | +3%
|-
| style="text-align:left" |
| style="text-align:right" | -2%
|-
| style="text-align:left" |
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
**
* ''Net income'' drivers:
**
**
*
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
=== Shareholders' equity ===
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | ''Opening Shareholders' equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" |
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" |
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | ''Closing
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
Line 827 ⟶ 722:
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) ''Net cash remittance'' trend:
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
Line 869 ⟶ 745:
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
Line 881 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
</div>
=== Solvency II at 224% ===
Line 897 ⟶ 770:
! class="col-s" style="text-align:right" | EOF
! class="col-s" style="text-align:right" | SCR
! class="col-s" style="text-align:right" | Solvency II ratio (
|-
| style="text-align:left" | FY24
Line 924 ⟶ 797:
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
Line 941 ⟶ 814:
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 965 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity
| style="text-align:right" | +2
|-
Line 982 ⟶ 855:
</div>
* Euro
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio impacts <sup>p. 25</sup>
! style="text-align:left" | Event
! class="col-s" style="text-align:right" | Impact (pts)
|-
| style="text-align:left" | Solvency II ratio as of December 31, 2025
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17
|}
</div>
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
*
=== Conclusion ===
*
*
*
*
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* ''
=== AXA Investor Relations | Keep in touch ===
* ''Investor Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
! class="col-m" style="text-align:right" | Location
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
== Appendices ==
*
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Economic maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
=== Structured and private credit assets ===
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right" | o/w 54% participating
|}
</div>
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
**
**
=== Table of contents ===
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,230 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
=== P&C | Focus on
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technical reserves ratios
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,283 ⟶ 1,383:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 600m
| style="text-align:right" | 4.0bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 450m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 400m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" |
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
* Covered via ''Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Return period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
| style="text-align:left" | 1/20y (95th percentile)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 1/10y (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | EUR billion
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
| style="text-align:left" | 2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| class="col-s" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== P&C | Margin analysis ===
Line 1,388 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | ''Current Accident Year Undiscounted Technical Margin''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" |
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" |
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" |
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
=== L&H | Margin analysis ===
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:right" | 479
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
{| class="wikitable fintable"
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
! style="text-align:left" | Underlying Earnings
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 4,229
| style="text-align:right" | +205
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" |
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Baseline
Line 1,647 ⟶ 1,662:
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Sovereign spreads +50bps
Line 1,653 ⟶ 1,668:
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Corporate spread +50bps
Line 1,659 ⟶ 1,674:
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" |
|-
| style="text-align:left" | Equities -25%
Line 1,669 ⟶ 1,684:
</div>
* ''Sustainability'' <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,679 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" | Climate transition financing
Line 1,692 ⟶ 1,708:
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
Line 1,704 ⟶ 1,720:
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64%
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of
| class="col-m" style="text-align:right" | 56%
|}
</div>
=== Sustainability Performance & Ratings ===
Line 1,724 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings
! style="text-align:left" |
! class="col-
|-
| style="text-align:left" | S&P Global percentile
| class="col-
|-
| style="text-align:left" | MSCI
| class="col-
|-
| style="text-align:left" | CDP
| class="col-
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-
|-
| style="text-align:left" | FTSE Russell
| class="col-
|}
</div>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
*
*
*
*
**
**
**
**
*
*
*
=== Glossary ===
*
*
*
*
*
*
*
*
*
*
*
*
*
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''
== Abbreviations ==
*
*
*
*
*
* ''AMF'': Autorité des marchés financiers
* ''
* ''AXA IM'': AXA Investment Managers
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* ''AY'': Accident Year
* ''
* ''
* ''
* ''
* ''CSA'': Corporate Sustainability Assessment
* ''
* ''
* ''
* ''
* ''
* ''EPS'': Earnings Per Share
* ''ESG'': Environmental, Social, and Governance
* ''ESMA'': European Securities and Markets Authority
* ''
* ''EUR'': Euro
* ''
* ''GAAP'': Generally Accepted Accounting Principles
* ''
* ''
* ''
* ''
* ''
* ''IFE'': Insurance Finance Expenses
* ''IFRS'': International Financial Reporting Standards
* ''
* ''
* ''
* ''
* ''LTV'': Loan-to-Value
* ''MSCI'': Morgan Stanley Capital International
*
*
*
*
*
*
*
*
*
*
* ''
* ''
* ''
* ''SHE'': Shareholders' Equity
* ''SME'': Small and Medium-sized Enterprises
* ''
* ''
* ''
* ''
*
*
| |||